As of today (2024-04-16), Bio-Techne's share price is $65.52.
Bio-Techne's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.71. Hence, Bio-Techne's Price-to-Operating-Cash-Flow Ratio for today is 38.25.
The historical rank and industry rank for Bio-Techne's Price-to-Operating-Cash-Flow or its related term are showing as below:
TECH'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 17.99 Med: 36.48 Max: 64.94
Current: 38.28
During the past 13 years, Bio-Techne's highest Price-to-Operating-Cash-Flow Ratio was 64.94. The lowest was 17.99. And the median was 36.48.
Bio-Techne's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $0.52.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.71.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bio-Techne was -5.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 11.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.10% per year.
During the past 13 years, Bio-Techne's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.10% per year. The lowest was -1.80% per year. And the median was 13.10% per year.
Bio-Techne Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Bio-Techne's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Bio-Techne Annual Data
|
|
Trend |
Jun14 |
Jun15 |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
44.66 |
50.70 |
51.75 |
43.72 |
51.93 |
|
Bio-Techne Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45.59 |
44.03 |
51.93 |
42.76 |
45.04 |
Competitive Comparison
For the Biotechnology subindustry, Bio-Techne's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Price-to-Operating-Cash-Flow Distribution
For the Biotechnology industry and Healthcare sector, Bio-Techne's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Price-to-Operating-Cash-Flow falls into.
Bio-Techne Price-to-Operating-Cash-Flow Calculation
Bio-Techne's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 65.52 | / | 1.713 |
| = | 38.25 |
Bio-Techne's Share Price of today is $65.52.
Bio-Techne's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.71.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Bio-Techne (Bio-Techne) Business Description
Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Executives
| Roeland Nusse |
director |
473 TENNESSEE, PALO ALTO CA 94306 |
| William Geist |
officer: PRESIDENT, PROTEIN SCIENCES |
900 MIDDLESEX TURNPIKE, C/O QUANTERIX CORPORATION, BILLERICA MA 01821 |
| Charles R. Kummeth |
director, officer: Chief Executive Officer |
425 MARTINGALE ROAD, SUITE 1000, SCHAUMBURG IL 60173-2213 |
| Shane Bohnen |
officer: SVP - General Counsel |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Brenda S. Furlow |
officer: SVP - General Counsel |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| John L Higgins |
director |
11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037 |
| Robert V Baumgartner |
director |
5775 WAYZATA BOULEVARD, SUITE 400, MINNEAPOLIS MN 55416 |
| Kim Kelderman |
officer: Pres. Diagnostics & Genom |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Norman David Eansor |
officer: SVP Biotech |
8100 SOUTHPARK WAY, A-8, LITTLETON CO 80120 |
| James Hippel |
officer: Chief Financial Officer |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Joseph D Keegan |
director |
C/O MOLECULAR DEVICES CORP, 1311 ORLEANS DRIVE, SUNNYVALE CA 94089 |
| Alpna Seth |
director |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
| Julie L Bushman |
director |
185 SOUTH 84TH STREET, SUITE 200, MILWAUKEE WI 53214 |
| Rupert Vessey |
director |
C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901 |
| Randolph C Steer |
director |
614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413 |
Bio-Techne (Bio-Techne) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your